Correlation Between Marizyme and BetterLife Pharma

Can any of the company-specific risk be diversified away by investing in both Marizyme and BetterLife Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marizyme and BetterLife Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Marizyme and BetterLife Pharma, you can compare the effects of market volatilities on Marizyme and BetterLife Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marizyme with a short position of BetterLife Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marizyme and BetterLife Pharma.

Diversification Opportunities for Marizyme and BetterLife Pharma

0.14

Correlation Coefficient

Marizyme  BetterLife Pharma

Average diversification

The 3 months correlation between Marizyme and BetterLife is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Marizyme and BetterLife Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BetterLife Pharma and Marizyme is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marizyme are associated (or correlated) with BetterLife Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BetterLife Pharma has no effect on the direction of Marizyme i.e., Marizyme and BetterLife Pharma go up and down completely randomly.

Pair Corralation between Marizyme and BetterLife Pharma

Given the investment horizon of 90 days Marizyme is expected to generate 2.45 times more return on investment than BetterLife Pharma. However, Marizyme is 2.45 times more volatile than BetterLife Pharma. It trades about 0.06 of its potential returns per unit of risk. BetterLife Pharma is currently generating about 0.03 per unit of risk. If you would invest  4.00  in Marizyme on September 13, 2024 and sell it today you would lose (1.00) from holding Marizyme or give up 25.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Marizyme  vs.  BetterLife Pharma

Marizyme

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Marizyme are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Marizyme displayed solid returns over the last few months and may actually be approaching a breakup point.

BetterLife Pharma

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in BetterLife Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BetterLife Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Marizyme and BetterLife Pharma

The main advantage of trading using opposite Marizyme and BetterLife Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marizyme position performs unexpectedly, BetterLife Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BetterLife Pharma will offset losses from the drop in BetterLife Pharma's long position.

The idea behind Marizyme and BetterLife Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.